Table 4.
Top five molecular networks associated with genetic differences in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis liver biopsies compared to healthy controls. Disease networks were identified using Ingenuity Pathway Analysis
|
Top molecular networks in NAFLD vs healthy control
| |
| Lipid metabolism, small molecule biochemistry, vitamin and mineral metabolism | 34 |
| Cell-to-cell signaling and interaction, cellular movement, hematological system development and function | 23 |
| Connective tissue disorders, inflammatory disease, organismal injury and abnormalities | 19 |
| Cellular development, connective tissue development and function, skeletal and muscular system development and function | 16 |
| Cell death and survival, neurological disease, organismal injury and abnormalities | 16 |
| Amino acid metabolism, molecular transport, small molecule biochemistry | 34 |
| Cellular development, skeletal and muscular system development and function, tissue development | 34 |
| Hereditary disorder, neurological disease, organismal injury and abnormalities | 32 |
| Digestive system development and function, lipid metabolism, small molecule biochemistry | 29 |
| Cell cycle, cell death and survival, cellular movement | 29 |
NAFLD: Non-alcoholic fatty liver disease.